Concourse Financial Group Securities, Inc. Exact Sciences Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 5,699 shares of EXAS stock, worth $259,874. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,699

Previous 6,222 8.41%

Holding current value

$259,874

Previous $423,000 24.35%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$49.33 - $71.97 $25,799 - $37,640	-523 Reduced 8.41%	5,699 $320,000
Q3 2024 Oct 10, 2024	SELL	$42.43 - $70.83 $61,735 - $103,057	-1,455 Reduced 18.95%	6,222 $423,000
Q2 2024 Jul 23, 2024	SELL	$41.33 - $74.26 $8,266 - $14,852	-200 Reduced 2.54%	7,677 $324,000
Q1 2024 Apr 30, 2024	SELL	$56.27 - $73.77 $24,252 - $31,794	-431 Reduced 5.19%	7,877 $543,000
Q4 2023 Feb 07, 2024	BUY	$59.06 - $75.72 $43,704 - $56,032	740 Added 9.78%	8,308 $614,000
Q3 2023 Oct 25, 2023	SELL	$65.94 - $99.04 $30,991 - $46,548	-470 Reduced 5.85%	7,568 $516,000
Q2 2023 Aug 10, 2023	SELL	$62.68 - $95.05 $33,596 - $50,946	-536 Reduced 6.25%	8,038 $754,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $26,709 - $40,055	-566 Reduced 6.19%	8,574 $581,000
Q4 2022 Jan 30, 2023	BUY	$30.35 - $53.15 $28,589 - $50,067	942 Added 11.49%	9,140 $0
Q3 2022 Nov 15, 2022	SELL	$31.97 - $49.37 $12,084 - $18,661	-378 Reduced 4.41%	8,198 $266,000
Q2 2022 Aug 09, 2022	SELL	$35.61 - $76.23 $6,765 - $14,483	-190 Reduced 2.17%	8,576 $338,000
Q1 2022 May 09, 2022	SELL	$57.56 - $82.54 $382,543 - $548,560	-6,646 Reduced 43.12%	8,766 $613,000
Q4 2021 Feb 07, 2022	BUY	$72.5 - $100.68 $253,605 - $352,178	3,498 Added 29.36%	15,412 $1.2 Million
Q3 2021 Nov 09, 2021	BUY	$90.24 - $124.05 $98,903 - $135,958	1,096 Added 10.13%	11,914 $1.14 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $125,223 - $186,203	1,337 Added 14.1%	10,818 $1.34 Million
Q1 2021 May 13, 2021	BUY	$116.57 - $155.01 $140,000 - $186,167	1,201 Added 14.5%	9,481 $1.25 Million
Q4 2020 Feb 02, 2021	BUY	$99.61 - $142.12 $67,734 - $96,641	680 Added 8.95%	8,280 $1.1 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $384,725 - $538,204	5,276 Added 227.02%	7,600 $775,000
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $1,226 - $2,040	22 Added 0.96%	2,324 $202,000
Q1 2020 May 13, 2020	BUY	$37.9 - $104.44 $21,527 - $59,321	568 Added 32.76%	2,302 $134,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $15,997 - $20,546	206 Added 13.48%	1,734 $160,000
Q3 2019 Nov 13, 2019	SELL	$90.37 - $122.49 $18,074 - $24,498	-200 Reduced 11.57%	1,528 $138,000
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $52,311 - $81,446	-844 Reduced 32.81%	1,728 $149,000
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $74,869 - $110,433	1,336 Added 108.09%	2,572 $162,000
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $59,686 - $99,621	1,236 New	1,236 $98,000

Others Institutions Holding EXAS

# of Institutions

668

Shares Held

152M

Call Options Held

4.25M

Put Options Held

1.89M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.07B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Exact Sciences Corp Transaction History